Where does Rainbow Medical Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rainbow Medical Ltd. ranks #5,789 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rainbow Medical Ltd. hold?

Rainbow Medical Ltd. holds 59 US utility patents granted between 2015 and 2023, spanning 8 technology areas.

What is Rainbow Medical Ltd.'s Innovation Score?

Rainbow Medical Ltd. has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rainbow Medical Ltd. focus on?

Rainbow Medical Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 36 patents, ranking #107 of 1,943 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Rainbow Medical Ltd.'s patent grant rate increasing or decreasing?

Rainbow Medical Ltd.'s recent grant velocity is +19% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Rainbow Medical Ltd.'s patents?

Rainbow Medical Ltd.'s patents average 20.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rainbow Medical Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rainbow Medical Ltd.

USPTO PatentsView assignee record - 59 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rainbow ranks #5,789 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 8 technology areas.

#5,789
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 20.1
avg claims per patent: +19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5789 · Foreign Corporation #5,789 · 59 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 59 grants
UPPER-Q #5,789/49,997
PHOTO-FINISH Otsuka Pharmaceutica…
CPC-NARROW A61N · 8 areas
INNOV-THIN 38.8/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +19% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Otsuka Pharmaceutical Factory, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rainbow’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (36%) Velocity 2.6 pts (7%) Breadth 10.0 pts (26%) Claim depth 12.0 pts (31%)

Qualcomm Incorporated · highest

85
Cradlepoint · near

39
Jahwa · near

39
Metso Minerals · near

39
Permobil AB · near

39
Rainbow Medical · this assignee

39
3D Lighting… · lowest

7

What this shows Rainbow's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rainbow?

Each dot is one of Rainbow’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rainbow’s own 20.1 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rainbow vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rainbow's grants concentrate

Rainbow Medical Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 61% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (11 grants) versus a trough of 1 in 2023. By volume, Rainbow sits between Otsuka Pharmaceutical Factory, Inc. and SI-Bone Inc..

Rainbow's three-year grant acceleration

From 2019–2021 to 2022–2024, Rainbow Medical Ltd. moved from 28 to 11 grants (0.39x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Otsuka Pharmaceut…

59
Pum-tech Korea

59
Plansee SE

59
Qingdao Pico Tech…

59
Rebellion Photoni…

59
Revision Military…

59
Shanghai IC R&D C…

59
Si-bone

59
Rainbow Medical ◀

59

What this shows Rainbow holds 59 patents at rank #5,789, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rainbow

By rank, the assignees closest to #5,789 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Rainbow's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rainbow, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Rainbow ranks #107 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Metso Minerals, Inc. 39 Jahwa Electronics Co., Ltd. 39 Cradlepoint, Inc. 39 Permobil AB 39

Similar claim depth

Nearest assignees by average claims per patent (20.1 here).

Applied Micro Circuits Corporation 20.1 avg Cardinal IG Company 20.1 avg Tactotek OY 20.1 avg VID Scale, Inc. 20.1 avg

Rainbow's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rainbow Medical Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	6.8%
2016	3	5.1%
2017	10	16.9%
2018	3	5.1%
2019	7	11.9%
2020	11	18.6%
2021	10	16.9%
2022	10	16.9%
2023	1	1.7%

Which technologies does Rainbow Medical Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 36

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 15

A61B - DIAGNOSIS; SURGERY; Identification 12

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rainbow Medical Ltd.'s patent record in context - here's where to go next.

Rainbow Medical Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 61% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #5,789 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rainbow Medical Ltd. against Otsuka Pharmaceutical Factory, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.